Human UTP14a Promotes Colorectal Cancer Progression by Forming a Positive Regulation Loop with C-Myc
Overview
Authors
Affiliations
Nucleolar protein hUTP14a is required for 18S rRNA processing and promotes p53 degradation. Here, we report that hUTP14a stabilizes c-Myc in colorectal cancer (CRC) progression. Firstly, nucleolar hUTP14a is upregulated in human CRC tissues. Mass spectrometry analysis identified c-Myc and its deubiquitinase ubiquitin-specific protease 36 (USP36) in the hUTP14a-specific complex. Importantly, hUTP14a interacts with c-Myc and protects c-Myc from ubiquitination and degradation in a USP36-dependent way. We further demonstrate that hUTP14a forms a complex with USP36/Fbw7γ to inhibit Fbw7γ-mediated c-Myc degradation. Ectopic expression of Flag-hUTP14a enriches c-Myc in the nucleolus, indicating hUTP14a stabilizes c-Myc in the nucleolus. Interestingly, c-Myc activates transcription of hUTP14a. Knockdown of hUTP14a by short hairpin RNA inhibits tumor growth and decreases c-Myc levels in mouse xenografts. Significantly, nucleolar hUTP14a and c-Myc are co-upregulated in human CRC tissues, and this co-upregulation indicates poor prognosis of CRC patients. Thus, disruption of hUTP14a-c-Myc regulation may provide a potential therapeutic strategy for a subset of CRC patients.
Duan R, Zhai Y, Wang Q, Zhao L, Wang Y, Yu N MedComm (2020). 2024; 5(11):e70003.
PMID: 39534558 PMC: 11555016. DOI: 10.1002/mco2.70003.
TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis.
Duan K, Fang K, Sui C Heliyon. 2024; 10(10):e30959.
PMID: 38813227 PMC: 11133704. DOI: 10.1016/j.heliyon.2024.e30959.
The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond.
Niu M, Liu Y, Shi J, Chen R, Zhang S, Li C Biomolecules. 2024; 14(5).
PMID: 38785979 PMC: 11118191. DOI: 10.3390/biom14050572.
SUMOylation regulation of ribosome biogenesis: Emerging roles for USP36.
Yang Y, Li Y, Sears R, Sun X, Dai M Front RNA Res. 2024; 2.
PMID: 38764604 PMC: 11101209. DOI: 10.3389/frnar.2024.1389104.
Liu J, Zhu Y, Wang H, Han C, Wang Y, Tang R Cancer Sci. 2024; 115(3):804-819.
PMID: 38182548 PMC: 10920983. DOI: 10.1111/cas.16049.